Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer (CA017078)

  • Details

ClinicalTrials.gov ID: NCT03661320
Diagnosis Type: NA
USOR Number: 18095

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

Randomized, Open-Label, Phase 3 Trial of Nivolumab plus Ipilimumab or Nivolumab plus Platinum-Doublet Chemotherapy versus Platinum-Doublet Chemotherapy in Early Stage NSCLC (CA209-816)

  • Details

ClinicalTrials.gov ID: NCT02998528
Diagnosis Type: NSCLC
USOR Number: 16161

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

Phase 3 Study of Sacituzumab Govitecan (IMMU-132) Versus Treatment of Physician's Choice (TPC) in subjects with Hormonal Receptor-Positive (HR+) Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer (MBC) who have failed at least two prior chemotherapy regimens (IMMU-132-09)

  • Details

ClinicalTrials.gov ID: NCT03901339
Diagnosis Type: NA
USOR Number: 18282

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

  • Details

ClinicalTrials.gov ID: NCT03390504
Diagnosis Type: NA
USOR Number: 17133

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 2, Open-label Study of Zanubrutinib (BGB-3111) in Patients with Relapsed or Refractory Marginal Zone Lymphoma (BGB-3111-214)

  • Details

ClinicalTrials.gov ID: NCT03846427
Diagnosis Type: NA
USOR Number: 18132

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

Single Arm, Open Label Phase 1b/2 Study of SGN-LIV1A in Combination with Pembrolizumab for First-Line Treatment of Patients with Unresectable Locally-Advanced or Metastatic Triple-Negative Breast Cancer (SGNLVA-002)

  • Details

ClinicalTrials.gov ID: NCT03310957
Diagnosis Type: NA
USOR Number: 18004

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number: 19079

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Multinational, Multicenter, Phase 2 Study of Tesetaxel plus a Reduced Dose of Capecitabine in Patients with HER2 Negative, Hormone Receptor Positive, Locally Advanced or Metastatic Breast Cancer Who Have Not Previously Received a Taxane(ODO-TE-B201)

  • Details

ClinicalTrials.gov ID: NCT03858972
Diagnosis Type: NA
USOR Number: 18238

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Brain Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Randomized, Multicenter, Phase 2 Study of DSP-7888 Dosing Emulsion in Combination with Bevacizumab versus Bevacizumab Alone in Patients with Recurrent or Progressive Glioblastoma following Initial Therapy (BBI-DSP7888-201G)

  • Details

ClinicalTrials.gov ID: NCT03149003
Diagnosis Type: NA
USOR Number: 17058

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A phase II, multicenter, randomized, open-label study to evaluate the safety and efficacy of 400 mg of ribociclib in combination with non-steroidal aromatase inhibitors for the treatment of pre- and postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer who received no prior therapy for advanced disease (CLEE011A2207)

  • Details

ClinicalTrials.gov ID: NCT03822468
Diagnosis Type: NA
USOR Number: 19004

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

INCMGA 0012-203: A Phase 2 Study of INCMGA00012 (PD-1 Inhibitor) in Participants With Selected Solid Tumors (POD1UM-203)

  • Details

ClinicalTrials.gov ID: NCT03679767
Diagnosis Type: NA
USOR Number: 18207

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants (KEYNOTE-789; MK-3475-789)

  • Details

ClinicalTrials.gov ID: NCT03515837
Diagnosis Type: NA
USOR Number: 19020

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Melanoma

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

INCMGA 0012-203: A Phase 2 Study of INCMGA00012 (PD-1 Inhibitor) in Participants With Selected Solid Tumors (POD1UM-203)

  • Details

ClinicalTrials.gov ID: NCT03679767
Diagnosis Type: NA
USOR Number: 18207

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Renal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

INCMGA 0012-203: A Phase 2 Study of INCMGA00012 (PD-1 Inhibitor) in Participants With Selected Solid Tumors (POD1UM-203)

  • Details

ClinicalTrials.gov ID: NCT03679767
Diagnosis Type: NA
USOR Number: 18207

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

INCMGA 0012-203: A Phase 2 Study of INCMGA00012 (PD-1 Inhibitor) in Participants With Selected Solid Tumors (POD1UM-203)

  • Details

ClinicalTrials.gov ID: NCT03679767
Diagnosis Type: NA
USOR Number: 18207

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer After Failure of Platinum-Based Regimen or Anti-PD-1/PD-L1 Based Immunotherapy (IMMU-132-06)

  • Details

ClinicalTrials.gov ID: NCT03547973
Diagnosis Type: ALL
USOR Number: 18283

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase II, Multicenter, Randomized, Open-Label, Controlled Study of M7824 versus Pembrolizumab as a First-line Treatment in Patients with PD-L1 Expressing Advanced Non-small Cell Lung Cancer(MS200647-0037)

  • Details

ClinicalTrials.gov ID: NCT03631706
Diagnosis Type: NSCLC
USOR Number: 18065

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: NA
USOR Number: 17079

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

Clovis CO-338-087/GOG-3020/ENGOT-ov45/NCRI/ATHENA: A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03522246
Diagnosis Type: NA
USOR Number: 17182

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Pages